世界のコレラワクチン（経口用）市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Cholera Vaccine (Oral Route) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z03142 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品

• 販売価格（消費税別）

Single User	￥504,600 (USD3,480)	▷ お問い合わせ
Multi User	￥756,900 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,009,200 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、コレラワクチン（経口用）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。コレラワクチン（経口用）の種類別市場規模（Shanchol、Dukoral、Vaxchora、その他）、用途別市場規模（病院、研究所、製薬・バイオテクノロジー企業、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・コレラワクチン（経口用）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：PaxVax、Sanofi、Valneva、EuBiologics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：Shanchol、Dukoral、Vaxchora、その他 ・用途別分析2016年-2026年：病院、研究所、製薬・バイオテクノロジー企業、その他 ・コレラワクチン（経口用）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・コレラワクチン（経口用）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・コレラワクチン（経口用）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・コレラワクチン（経口用）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・コレラワクチン（経口用）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Cholera Vaccine (Oral Route) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Cholera Vaccine (Oral Route) size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Cholera Vaccine (Oral Route) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Cholera Vaccine (Oral Route) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Shanchol
Dukoral
Vaxchora
Others

Market segment by Application can be divided into
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others

The key market players for global Cholera Vaccine (Oral Route) market are listed below:
PaxVax
Sanofi
Valneva
EuBiologics

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Cholera Vaccine (Oral Route) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cholera Vaccine (Oral Route) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Shanchol
1.2.3 Dukoral
1.2.4 Vaxchora
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Cholera Vaccine (Oral Route) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Global Cholera Vaccine (Oral Route) Market Size & Forecast
1.4.1 Global Cholera Vaccine (Oral Route) Sales in Value (2016-2026))
1.4.2 Global Cholera Vaccine (Oral Route) Sales in Volume (2016-2026)
1.4.3 Global Cholera Vaccine (Oral Route) Price by Type (2016-2026) & (USD/Unit)
1.5 Global Cholera Vaccine (Oral Route) Production Capacity Analysis
1.5.1 Global Cholera Vaccine (Oral Route) Total Production Capacity (2016-2026)
1.5.2 Global Cholera Vaccine (Oral Route) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cholera Vaccine (Oral Route) Market Drivers
1.6.2 Cholera Vaccine (Oral Route) Market Restraints
1.6.3 Cholera Vaccine (Oral Route) Trends Analysis
2 Manufacturers Profiles
2.1 PaxVax
2.1.1 PaxVax Details
2.1.2 PaxVax Major Business
2.1.3 PaxVax Cholera Vaccine (Oral Route) Product and Services
2.1.4 PaxVax Cholera Vaccine (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Cholera Vaccine (Oral Route) Product and Services
2.2.4 Sanofi Cholera Vaccine (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Valneva
2.3.1 Valneva Details
2.3.2 Valneva Major Business
2.3.3 Valneva Cholera Vaccine (Oral Route) Product and Services
2.3.4 Valneva Cholera Vaccine (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 EuBiologics
2.4.1 EuBiologics Details
2.4.2 EuBiologics Major Business
2.4.3 EuBiologics Cholera Vaccine (Oral Route) Product and Services
2.4.4 EuBiologics Cholera Vaccine (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Cholera Vaccine (Oral Route) Sales by Manufacturer
3.1 Global Cholera Vaccine (Oral Route) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Cholera Vaccine (Oral Route) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Cholera Vaccine (Oral Route)
3.4 Market Concentration Rate
3.4.1 Top 3 Cholera Vaccine (Oral Route) Manufacturer Market Share
3.4.2 Top 6 Cholera Vaccine (Oral Route) Manufacturer Market Share
3.5 Global Cholera Vaccine (Oral Route) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Cholera Vaccine (Oral Route) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cholera Vaccine (Oral Route) Market Size by Region
4.1.1 Global Cholera Vaccine (Oral Route) Sales in Volume by Region (2016-2026)
4.1.2 Global Cholera Vaccine (Oral Route) Revenue by Region (2016-2026)
4.2 North America Cholera Vaccine (Oral Route) Revenue (2016-2026)
4.3 Europe Cholera Vaccine (Oral Route) Revenue (2016-2026)
4.4 Asia-Pacific Cholera Vaccine (Oral Route) Revenue (2016-2026)
4.5 South America Cholera Vaccine (Oral Route) Revenue (2016-2026)
4.6 Middle East and Africa Cholera Vaccine (Oral Route) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Cholera Vaccine (Oral Route) Sales in Volume by Type (2016-2026)
5.2 Global Cholera Vaccine (Oral Route) Revenue by Type (2016-2026)
5.3 Global Cholera Vaccine (Oral Route) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Cholera Vaccine (Oral Route) Sales in Volume by Application (2016-2026)
6.2 Global Cholera Vaccine (Oral Route) Revenue by Application (2016-2026)
6.3 Global Cholera Vaccine (Oral Route) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Cholera Vaccine (Oral Route) Sales by Type (2016-2026)
7.2 North America Cholera Vaccine (Oral Route) Sales by Application (2016-2026)
7.3 North America Cholera Vaccine (Oral Route) Market Size by Country
7.3.1 North America Cholera Vaccine (Oral Route) Sales in Volume by Country (2016-2026)
7.3.2 North America Cholera Vaccine (Oral Route) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Cholera Vaccine (Oral Route) Sales by Type (2016-2026)
8.2 Europe Cholera Vaccine (Oral Route) Sales by Application (2016-2026)
8.3 Europe Cholera Vaccine (Oral Route) Market Size by Country
8.3.1 Europe Cholera Vaccine (Oral Route) Sales in Volume by Country (2016-2026)
8.3.2 Europe Cholera Vaccine (Oral Route) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Cholera Vaccine (Oral Route) Sales by Type (2016-2026)
9.2 Asia-Pacific Cholera Vaccine (Oral Route) Sales by Application (2016-2026)
9.3 Asia-Pacific Cholera Vaccine (Oral Route) Market Size by Region
9.3.1 Asia-Pacific Cholera Vaccine (Oral Route) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Cholera Vaccine (Oral Route) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Cholera Vaccine (Oral Route) Sales by Type (2016-2026)
10.2 South America Cholera Vaccine (Oral Route) Sales by Application (2016-2026)
10.3 South America Cholera Vaccine (Oral Route) Market Size by Country
10.3.1 South America Cholera Vaccine (Oral Route) Sales in Volume by Country (2016-2026)
10.3.2 South America Cholera Vaccine (Oral Route) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cholera Vaccine (Oral Route) Sales by Type (2016-2026)
11.2 Middle East & Africa Cholera Vaccine (Oral Route) Sales by Application (2016-2026)
11.3 Middle East & Africa Cholera Vaccine (Oral Route) Market Size by Country
11.3.1 Middle East & Africa Cholera Vaccine (Oral Route) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Cholera Vaccine (Oral Route) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Cholera Vaccine (Oral Route) Typical Distributors
12.3 Cholera Vaccine (Oral Route) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Cholera Vaccine (Oral Route) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Cholera Vaccine (Oral Route) Revenue by Application, (USD Million), 2021-2026
Table 3. PaxVax Basic Information, Manufacturing Base and Competitors
Table 4. PaxVax Major Business
Table 5. PaxVax Cholera Vaccine (Oral Route) Product and Services
Table 6. PaxVax Cholera Vaccine (Oral Route) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Major Business
Table 9. Sanofi Cholera Vaccine (Oral Route) Product and Services
Table 10. Sanofi Cholera Vaccine (Oral Route) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Valneva Basic Information, Manufacturing Base and Competitors
Table 12. Valneva Major Business
Table 13. Valneva Cholera Vaccine (Oral Route) Product and Services
Table 14. Valneva Cholera Vaccine (Oral Route) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 16. EuBiologics Major Business
Table 17. EuBiologics Cholera Vaccine (Oral Route) Product and Services
Table 18. EuBiologics Cholera Vaccine (Oral Route) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global Cholera Vaccine (Oral Route) Sales by Manufacturer (2019-2021e) & (K Units)
Table 20. Global Cholera Vaccine (Oral Route) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in Cholera Vaccine (Oral Route), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global Cholera Vaccine (Oral Route) Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and Cholera Vaccine (Oral Route) Production Site of Key Manufacturer
Table 24. Global Cholera Vaccine (Oral Route) Sales by Region (2016-2021e) & (K Units)
Table 25. Global Cholera Vaccine (Oral Route) Sales by Region (2021-2026) & (K Units)
Table 26. Global Cholera Vaccine (Oral Route) Revenue by Region (2016-2021e) & (USD Million)
Table 27. Global Cholera Vaccine (Oral Route) Revenue by Region (2021-2026) & (USD Million)
Table 28. Global Cholera Vaccine (Oral Route) Sales by Type (2016-2021e) & (K Units)
Table 29. Global Cholera Vaccine (Oral Route) Sales by Type (2021-2026) & (K Units)
Table 30. Global Cholera Vaccine (Oral Route) Revenue by Type (2016-2021e) & (USD Million)
Table 31. Global Cholera Vaccine (Oral Route) Revenue by Type (2021-2026) & (USD Million)
Table 32. Global Cholera Vaccine (Oral Route) Price by Type (2016-2021e) & (USD/Unit)
Table 33. Global Cholera Vaccine (Oral Route) Price by Type (2021-2026) & (USD/Unit)
Table 34. Global Cholera Vaccine (Oral Route) Sales by Application (2016-2021e) & (K Units)
Table 35. Global Cholera Vaccine (Oral Route) Sales by Application (2021-2026) & (K Units)
Table 36. Global Cholera Vaccine (Oral Route) Revenue by Application (2016-2021e) & (USD Million)
Table 37. Global Cholera Vaccine (Oral Route) Revenue by Application (2021-2026) & (USD Million)
Table 38. Global Cholera Vaccine (Oral Route) Price by Application (2016-2021e) & (USD/Unit)
Table 39. Global Cholera Vaccine (Oral Route) Price by Application (2021-2026) & (USD/Unit)
Table 40. North America Cholera Vaccine (Oral Route) Sales by Country (2016-2021e) & (K Units)
Table 41. North America Cholera Vaccine (Oral Route) Sales by Country (2021-2026) & (K Units)
Table 42. North America Cholera Vaccine (Oral Route) Revenue by Country (2016-2021e) & (USD Million)
Table 43. North America Cholera Vaccine (Oral Route) Revenue by Country (2021-2026) & (USD Million)
Table 44. North America Cholera Vaccine (Oral Route) Sales by Type (2016-2021e) & (K Units)
Table 45. North America Cholera Vaccine (Oral Route) Sales by Type (2021-2026) & (K Units)
Table 46. North America Cholera Vaccine (Oral Route) Sales by Application (2016-2021e) & (K Units)
Table 47. North America Cholera Vaccine (Oral Route) Sales by Application (2021-2026) & (K Units)
Table 48. Europe Cholera Vaccine (Oral Route) Sales by Country (2016-2021e) & (K Units)
Table 49. Europe Cholera Vaccine (Oral Route) Sales by Country (2021-2026) & (K Units)
Table 50. Europe Cholera Vaccine (Oral Route) Revenue by Country (2016-2021e) & (USD Million)
Table 51. Europe Cholera Vaccine (Oral Route) Revenue by Country (2021-2026) & (USD Million)
Table 52. Europe Cholera Vaccine (Oral Route) Sales by Type (2016-2021e) & (K Units)
Table 53. Europe Cholera Vaccine (Oral Route) Sales by Type (2021-2026) & (K Units)
Table 54. Europe Cholera Vaccine (Oral Route) Sales by Application (2016-2021e) & (K Units)
Table 55. Europe Cholera Vaccine (Oral Route) Sales by Application (2021-2026) & (K Units)
Table 56. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Region (2016-2021e) & (K Units)
Table 57. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Region (2021-2026) & (K Units)
Table 58. Asia-Pacific Cholera Vaccine (Oral Route) Revenue by Region (2016-2021e) & (USD Million)
Table 59. Asia-Pacific Cholera Vaccine (Oral Route) Revenue by Region (2021-2026) & (USD Million)
Table 60. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Type (2016-2021e) & (K Units)
Table 61. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Type (2021-2026) & (K Units)
Table 62. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Application (2016-2021e) & (K Units)
Table 63. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Application (2021-2026) & (K Units)
Table 64. South America Cholera Vaccine (Oral Route) Sales by Country (2016-2021e) & (K Units)
Table 65. South America Cholera Vaccine (Oral Route) Sales by Country (2021-2026) & (K Units)
Table 66. South America Cholera Vaccine (Oral Route) Revenue by Country (2016-2021e) & (USD Million)
Table 67. South America Cholera Vaccine (Oral Route) Revenue by Country (2021-2026) & (USD Million)
Table 68. South America Cholera Vaccine (Oral Route) Sales by Type (2016-2021e) & (K Units)
Table 69. South America Cholera Vaccine (Oral Route) Sales by Type (2021-2026) & (K Units)
Table 70. South America Cholera Vaccine (Oral Route) Sales by Application (2016-2021e) & (K Units)
Table 71. South America Cholera Vaccine (Oral Route) Sales by Application (2021-2026) & (K Units)
Table 72. Middle East & Africa Cholera Vaccine (Oral Route) Sales by Country (2016-2021e) & (K Units)
Table 73. Middle East & Africa Cholera Vaccine (Oral Route) Sales by Country (2021-2026) & (K Units)
Table 74. Middle East & Africa Cholera Vaccine (Oral Route) Revenue by Country (2016-2021e) & (USD Million)
Table 75. Middle East & Africa Cholera Vaccine (Oral Route) Revenue by Country (2021-2026) & (USD Million)
Table 76. Middle East & Africa Cholera Vaccine (Oral Route) Sales by Type (2016-2021e) & (K Units)
Table 77. Middle East & Africa Cholera Vaccine (Oral Route) Sales by Type (2021-2026) & (K Units)
Table 78. Middle East & Africa Cholera Vaccine (Oral Route) Sales by Application (2016-2021e) & (K Units)
Table 79. Middle East & Africa Cholera Vaccine (Oral Route) Sales by Application (2021-2026) & (K Units)
Table 80. Direct Channel Pros & Cons
Table 81. Indirect Channel Pros & Cons
Table 82. Cholera Vaccine (Oral Route) Typical Distributors
Table 83. Cholera Vaccine (Oral Route) Typical Customers
List of Figures
Figure 1. Cholera Vaccine (Oral Route) Picture
Figure 2. Global Cholera Vaccine (Oral Route) Sales Market Share by Type in 2020
Figure 3. Shanchol
Figure 4. Dukoral
Figure 5. Vaxchora
Figure 6. Others
Figure 7. Global Cholera Vaccine (Oral Route) Sales Market Share by Application in 2020
Figure 8. Hospital
Figure 9. Research & Academic Laboratories
Figure 10. Pharmaceutical & Biotechnology Companies
Figure 11. Others
Figure 12. Global Cholera Vaccine (Oral Route) Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Cholera Vaccine (Oral Route) Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Cholera Vaccine (Oral Route) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Cholera Vaccine (Oral Route) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Cholera Vaccine (Oral Route) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Cholera Vaccine (Oral Route) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Cholera Vaccine (Oral Route) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Cholera Vaccine (Oral Route) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Cholera Vaccine (Oral Route) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Cholera Vaccine (Oral Route) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Cholera Vaccine (Oral Route) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Cholera Vaccine (Oral Route) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Cholera Vaccine (Oral Route) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Cholera Vaccine (Oral Route) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Cholera Vaccine (Oral Route) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Cholera Vaccine (Oral Route) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Cholera Vaccine (Oral Route) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Cholera Vaccine (Oral Route) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Cholera Vaccine (Oral Route) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Cholera Vaccine (Oral Route) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Cholera Vaccine (Oral Route) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Cholera Vaccine (Oral Route) Sales (2016-2026) & (K Units)
Figure 34. Global Cholera Vaccine (Oral Route) Production Capacity (2016-2026) & (K Units)
Figure 35. Global Cholera Vaccine (Oral Route) Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Cholera Vaccine (Oral Route) Market Drivers
Figure 37. Cholera Vaccine (Oral Route) Market Restraints
Figure 38. Cholera Vaccine (Oral Route) Market Trends
Figure 39. Global Cholera Vaccine (Oral Route) Sales Market Share by Manufacturer in 2020
Figure 40. Global Cholera Vaccine (Oral Route) Revenue Market Share by Manufacturer in 2020
Figure 41. Cholera Vaccine (Oral Route) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Cholera Vaccine (Oral Route) Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Cholera Vaccine (Oral Route) Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Cholera Vaccine (Oral Route) Sales Market Share by Region (2016-2026)
Figure 45. Global Cholera Vaccine (Oral Route) Revenue Market Share by Region (2016-2026)
Figure 46. North America Cholera Vaccine (Oral Route) Revenue (2016-2026) & (USD Million)
Figure 47. Europe Cholera Vaccine (Oral Route) Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Cholera Vaccine (Oral Route) Revenue (2016-2026) & (USD Million)
Figure 49. South America Cholera Vaccine (Oral Route) Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Cholera Vaccine (Oral Route) Revenue (2016-2026) & (USD Million)
Figure 51. Global Cholera Vaccine (Oral Route) Sales Market Share by Type (2016-2026)
Figure 52. Global Cholera Vaccine (Oral Route) Revenue Market Share by Type (2016-2026)
Figure 53. Global Cholera Vaccine (Oral Route) Price by Type (2016-2026) & (USD/Unit)
Figure 54. Global Cholera Vaccine (Oral Route) Sales Market Share by Application (2016-2026)
Figure 55. Global Cholera Vaccine (Oral Route) Revenue Market Share by Application (2016-2026)
Figure 56. Global Cholera Vaccine (Oral Route) Price by Application (2016-2026) & (USD/Unit)
Figure 57. North America Cholera Vaccine (Oral Route) Sales Market Share by Country (2016-2026)
Figure 58. North America Cholera Vaccine (Oral Route) Revenue Market Share by Country (2016-2026)
Figure 59. North America Cholera Vaccine (Oral Route) Sales Market Share by Type (2016-2026)
Figure 60. North America Cholera Vaccine (Oral Route) Sales Market Share by Application (2016-2026)
Figure 61. Europe Cholera Vaccine (Oral Route) Sales Market Share by Country (2016-2026)
Figure 62. Europe Cholera Vaccine (Oral Route) Revenue Market Share by Country (2016-2026)
Figure 63. Europe Cholera Vaccine (Oral Route) Sales Market Share by Type (2016-2026)
Figure 64. Europe Cholera Vaccine (Oral Route) Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Cholera Vaccine (Oral Route) Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share by Application (2016-2026)
Figure 69. South America Cholera Vaccine (Oral Route) Sales Market Share by Country (2016-2026)
Figure 70. South America Cholera Vaccine (Oral Route) Revenue Market Share by Country (2016-2026)
Figure 71. South America Cholera Vaccine (Oral Route) Sales Market Share by Type (2016-2026)
Figure 72. South America Cholera Vaccine (Oral Route) Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Cholera Vaccine (Oral Route) Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Cholera Vaccine (Oral Route) Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Cholera Vaccine (Oral Route) Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Cholera Vaccine (Oral Route) Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source

---